Home | News | News Archive | 2010 | GSK Biologics Vaccine Manufacture, Singapore

News Search


GSK Biologics Vaccine Manufacture, Singapore

GSK Biologics Vaccine Manufacture, Singapore

PM Group was selected by GSK Biologics to develop a C&Q strategy in partnership with its in-house team for a new Biologics facility in Singapore.

PM Group has worked with GlaxoSmithKline for over 30 years and more recently with GSK Biologics. PM Group was selected by GSK Biologics to develop a Commissioning & Qualification (C&Q) strategy in partnership with its in-house team for its new Biologics facility in Singapore.

A team of C&Q specialists worked closely with GSK's team to successfully deliver this project. PM Group was subsequently appointed to develop a C&Q strategy for GSK Biologics' facility in Shenzhen, China.